NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 10.21% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 8.22% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 6.93% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.42% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.12% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.33% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.40% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.32% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.17% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.79% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.65% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.58% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.51% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.45% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.42% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.41% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.35% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.34% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.27% |